Abstract:Abstract The primary mechanism of secondary injury after cerebral ischemia may be the brain inflammation that emerges after an ischemic stroke, which promotes neuronal death and inhibits nerve tissue regeneration. As the first immune cells to be activated after an ischemic stroke, microglia play an important immunomodulatory role in the progression of the condition. After an ischemic stroke, peripheral blood immune cells (mainly T cells) are recruited to the central nervous system by chemokines secreted by immune cells in the brain, where they interact with central nervous system cells (mainly microglia) to trigger a secondary neuroimmune response. This review summarizes the interactions between T cells and microglia in the immune-inflammatory processes of ischemic stroke. We found that, during ischemic stroke, T cells and microglia demonstrate a more pronounced synergistic effect. Th1, Th17, and M1 microglia can co-secrete proinflammatory factors, such as interferon-γ, tumor necrosis factor-β, and interleukin-1α, to promote neuroinflammation and exacerbate brain injury. Th2, Treg, and M2 microglia jointly secrete anti-inflammatory factors, such as interleukin-4, interleukin-10, and transforming growth factor-β, to inhibit the progression of neuroinflammation, as well as growth factors such as brain-derived neurotrophic factor to promote nerve regeneration and repair brain injury. Immune interactions between microglia and T cells influence the direction of the subsequent neuroinflammation, which in turn determines the prognosis of ischemic stroke patients. Clinical trials have been conducted on the ways to modulate the interactions between T cells and microglia toward anti-inflammatory communication using the immunosuppressant fingolimod or overdosing with Treg cells to promote neural tissue repair and reduce the damage caused by ischemic stroke. However, such studies have been relatively infrequent, and clinical experience is still insufficient. In summary, in ischemic stroke, T cell subsets and activated microglia act synergistically to regulate inflammatory progression, mainly by secreting inflammatory factors. In the future, a key research direction for ischemic stroke treatment could be rooted in the enhancement of anti-inflammatory factor secretion by promoting the generation of Th2 and Treg cells, along with the activation of M2-type microglia. These approaches may alleviate neuroinflammation and facilitate the repair of neural tissues.

Double-negative T cells remarkably promote neuroinflammation after ischemic stroke

Abstract TP253: Double Negative T Cells with FasL Mutation Promote M2-Microglial Polarization by Inhibiting PTPN2/TNF-α Pathway in Experimental Stroke

Abstract T P222: Fasl Mutation Facilitates Double Negative T Cell Accumulation and Modulates Microglia Activation in Ischemic Stroke

TCRαβ + NK1.1 - CD4 - CD8 - double-negative T cells inhibit central and peripheral inflammation and ameliorate ischemic stroke in mice

Double negative T cells promote surgery-induced neuroinflammation, microglial engulfment and cognitive dysfunction via the IL-17/CEBPβ/C3 pathway in adult mice

T Cells Modulate the Microglial Response to Brain Ischemia

Regulatory T Cell is Critical for Interleukin-33-mediated Neuroprotection Against Stroke.

Long-Term Accumulation of T Cytotoxic 1, T Cytotoxic 17, and T Cytotoxic 17/1 Cells in the Brain Contributes to Microglia-Mediated Chronic Neuroinflammation After Ischemic Stroke

Double‐negative T cells mediate M1 polarization of microglial cells via TNF‐α‐NLRP3 to aggravate neuroinflammation and cognitive impairment in Alzheimer's disease mice

Specific depletion of resident microglia in the early stage of stroke reduces cerebral ischemic damage

Γδ T Cells Aggravate Blood–brain-Barrier Injury Via IL-17A in Experimental Ischemic Stroke

Silencing of microRNA-494 inhibits the neurotoxic Th1 shift via regulating HDAC2-STAT4 cascade in ischaemic stroke

Improving stroke prognosis by TLR4 KO to enhance N2 neutrophil infiltration and reduce M1 macrophage polarization

Increased Peripheral CD137 Expression in a Mouse Model of Permanent Focal Cerebral Ischemia

FasL Incapacitation Alleviates CD4+ T Cells-Induced Brain Injury Through Remodeling of Microglia Polarization in Mouse Ischemic Stroke.

PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1

Abstract T P202: Crosstalk Between Microglia and T Cells Mediated by FasL after Cerebral Ischemia

Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke

Noncanonical contribution of microglial transcription factor NR4A1 to post-stroke recovery through TNF mRNA destabilization.

Toll-Like Receptors Mediate Opposing Dendritic Cell Effects on Treg/Th17 Balance in Mice With Intracerebral Hemorrhage

T cell interactions with microglia in immuneinflammatory processes of ischemic stroke